TriSalus Life Sciences Inc Sustainability Reports
TriSalus Life Sciences, Inc. is a medical technology and clinical-stage immunotherapy company that develops drug delivery systems and therapeutics for treating liver and pancreatic tumors. Its proprietary Pressure-Enabled Regional Immuno-Oncology (PERIO) platform utilizes pressure-enabled drug delivery technology to improve therapeutic distribution and uptake.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00Z1TKRH7
1 reports from 2023 to 2023